Peptide Therapy

Peptide Safety

Safety profiles, monitoring requirements, and risk assessment across peptide compounds.

19 articles · 165 min total
01

Methylene Blue Drug Interactions: Serotonin Syndrome Risk and What to Avoid

Methylene blue is a potent MAOI that can trigger life-threatening serotonin syndrome. Learn which medications are dangerous to combine and clinical safety protocols.

Methylene Blue Drug Interactions: Serotonin Syndrome Risk and What to Avoid
02

BPC-157 Contraindications: Who Should Not Use This Peptide

A clinical guide to BPC-157 contraindications, relative cautions, and drug interactions — covering cancer patients, transplant recipients, pregnancy, and autoimmune conditions.

BPC-157 Contraindications: Who Should Not Use This Peptide
03

Berberine Drug Interactions: What Every Patient on Berberine Needs to Know

Berberine inhibits CYP3A4 and P-gp, creating clinically significant interactions with statins, warfarin, cyclosporine, and more. A physician's evidence-based guide.

Berberine Drug Interactions: What Every Patient on Berberine Needs to Know
04

Who Should NOT Take Ashwagandha: Contraindications, Drug Interactions & Safety Guide

Ashwagandha is generally well-tolerated, but specific groups face real risks. A physician reviews thyroid effects, autoimmune concerns, drug interactions, and who to avoid it.

Who Should NOT Take Ashwagandha: Contraindications, Drug Interactions & Safety Guide
05

Metformin in Chronic Kidney Disease: eGFR Thresholds, Dosing, and When to Stop

Evidence-based guide to metformin dosing in CKD patients. eGFR cutoffs, lactic acidosis risk, FDA label changes, and how longevity physicians adjust protocol for renal impairment.

Metformin in Chronic Kidney Disease: eGFR Thresholds, Dosing, and When to Stop
06

NAD+ IV Therapy Contraindications: Who Should Avoid It and Why

A physician's guide to NAD+ IV therapy contraindications — cancer history, active infections, G6PD deficiency, cardiac conditions, and pregnancy.

NAD+ IV Therapy Contraindications: Who Should Avoid It and Why
07

Chelation Therapy Safety: Risks, Contraindications, and What to Monitor

A physician's guide to chelation therapy safety — covering EDTA, DMPS, and DMSA risks, contraindications, mineral depletion, and clinical monitoring protocols.

Chelation Therapy Safety: Risks, Contraindications, and What to Monitor
08

Ozone Therapy Risks: A Physician's Honest Assessment

A clinical breakdown of ozone therapy risks by administration route, contraindications, and how to evaluate whether ozone treatment is appropriate for you.

Ozone Therapy Risks: A Physician's Honest Assessment
09

NAD+ IV Side Effects: What to Expect and How to Manage Them

A physician's guide to NAD+ IV therapy side effects: what causes them, which are common vs serious, how to minimize discomfort, and who should avoid treatment.

NAD+ IV Side Effects: What to Expect and How to Manage Them
10

Is Peptide Therapy FDA Approved? The Honest Regulatory Picture

Honest physician's answer about FDA approval for peptide therapy. Which peptides are approved, which are investigational, off-label use, and the European regulatory landscape.

Is Peptide Therapy FDA Approved? The Honest Regulatory Picture
11

BPC-157 Side Effects: What Patients Actually Report

Honest physician assessment of BPC-157 side effects, contraindications, FDA status, and what patients report. Evidence levels clearly distinguished.

BPC-157 Side Effects: What Patients Actually Report
12

Chelation Therapy Side Effects and Safety

Complete guide to chelation therapy side effects. Common reactions, serious risks, mineral depletion, monitoring requirements, and how to minimize adverse effects.

Chelation Therapy Side Effects and Safety
13

PEMF Therapy Side Effects: What to Expect

What to expect during and after PEMF therapy — common responses, contraindications, how to titrate sessions, and when temporary symptom increases are normal.

PEMF Therapy Side Effects: What to Expect
14

Pentosan Polysulfate Eye Toxicity: Maculopathy Risk

Pentosan polysulfate maculopathy explained by Dr. Julian Douwes. Retinal toxicity risk, screening guidelines, reversibility questions, and what every PPS user must know.

Pentosan Polysulfate Eye Toxicity: Maculopathy Risk
15

BPC-157 Side Effects: What the Evidence Actually Shows

Honest assessment of BPC-157 side effects, safety data, FDA warnings, and theoretical risks. What we know, what we don't, and what to watch for.

BPC-157 Side Effects: What the Evidence Actually Shows
16

TB-500 Side Effects and Safety

Honest assessment of TB-500 side effects, WADA ban context, theoretical risks, and what clinical experience shows about Thymosin Beta-4 safety.

TB-500 Side Effects and Safety
17

How to Inject Peptides: A Step-by-Step Patient Guide

Step-by-step guide to subcutaneous peptide injection. Equipment, reconstitution, injection sites, rotation, storage, and sterility from a physician's perspective.

How to Inject Peptides: A Step-by-Step Patient Guide
18

Dihexa Safety: The c-Met Cancer Risk Question

Dihexa safety analysis by Dr. Julian Douwes. The HGF/c-Met oncogenic pathway concern, retracted research, failed clinical trials, and what patients must understand.

Dihexa Safety: The c-Met Cancer Risk Question
19

Peptide Safety: What You Need to Know

Comprehensive guide to peptide therapy safety. Regulatory status, quality concerns, side effects, contraindications, and why physician oversight matters.

Peptide Safety: What You Need to Know
← Back to Peptide Therapy